These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24363701)

  • 21. The release mechanism of an oral controlled-release delivery system for indomethacin.
    Talukdar MM; Rombaut P; Kinget R
    Pharm Dev Technol; 1998 Feb; 3(1):1-6. PubMed ID: 9532594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.
    Adeleye OA; Femi-Oyewo MN; Odeniyi MA
    Polim Med; 2014; 44(4):209-20. PubMed ID: 25932902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of a sustained-release tablets of metformin hydrochloride using hydrophilic synthetic and hydrophobic natural polymers.
    Wadher KJ; Kakde RB; Umekar MJ
    Indian J Pharm Sci; 2011 Mar; 73(2):208-15. PubMed ID: 22303065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and in vitro evaluation of directly compressed controlled release tablets designed from the Co-precipitates.
    Khan KA; Khan GM; Jan SU; Rehman A; Mehsud S
    Pak J Pharm Sci; 2018 Mar; 31(2):455-461. PubMed ID: 29618434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro-in vivo evaluation of xanthan gum and eudragit inter polyelectrolyte complex based sustained release tablets.
    Deb TK; Ramireddy B; Moin A; Shivakumar HG
    Int J Pharm Investig; 2015; 5(1):65-72. PubMed ID: 25599035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and Evaluation of Cephalexin Extended-release Matrix Tablets Using Hydroxy Propyl Methyl Cellulose as Rate-controlling Polymer.
    Vijay J; Sahadevan J; Prabhakaran R; Gilhotra RM
    J Young Pharm; 2012 Jan; 4(1):3-12. PubMed ID: 22523453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E168-E174. PubMed ID: 28290039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and evaluation of gastro-retentive floating bilayer tablet for the treatment of hypertension.
    Maddiboyina B; Hanumanaik M; Nakkala RK; Jhawat V; Rawat P; Alam A; Foudah AI; Alrobaian MM; Shukla R; Singh S; Kesharwani P
    Heliyon; 2020 Nov; 6(11):e05459. PubMed ID: 33241144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Gum of Moringa oleifera as a Binder and Release Retardant in Tablet Formulation.
    Panda DS; Choudhury NS; Yedukondalu M; Si S; Gupta R
    Indian J Pharm Sci; 2008 Sep; 70(5):614-8. PubMed ID: 21394258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and evaluation of floating tablets of liquorice extract.
    Ram HN; Lachake P; Kaushik U; Shreedhara CS
    Pharmacognosy Res; 2010 Sep; 2(5):304-8. PubMed ID: 21589757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once daily controlled release matrix tablet of Prochlorperazine maleate: influence of Ethocel® and/or Methocel® on in vitro drug release and bioavailability.
    Badshah A; Subhan F; Shah NH; Bukhari NI; Saeed M; Shah KU
    Drug Dev Ind Pharm; 2012 Feb; 38(2):190-9. PubMed ID: 21749268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and development of matrix tablets of tramadol using katira gum as release modifier.
    Singh I; Kumar P; Kumar S; Rana V
    Yakugaku Zasshi; 2010 Sep; 130(9):1225-31. PubMed ID: 20823680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation and Evaluation of Hydroxypropyl Methylcellulose-based Controlled Release Matrix Tablets for Theophylline.
    Sekharan TR; Palanichamy S; Tamilvanan S; Shanmuganathan S; Thirupathi AT
    Indian J Pharm Sci; 2011 Jul; 73(4):451-6. PubMed ID: 22707833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
    Loh ZC; Elkordy AA
    Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colon specific drug delivery of tramadol HCl for chronotherapeutics of arthritis.
    Kadiyam R; Muzib YI
    Int J Pharm Investig; 2015; 5(1):43-9. PubMed ID: 25599032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system.
    Mehta R; Chawla A; Sharma P; Pawar P
    J Adv Pharm Technol Res; 2013 Jan; 4(1):31-41. PubMed ID: 23662280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Extended-Release Oral Flexible Tablet (ER-OFT) Formulation for Pediatric and Geriatric Compliance: an Age-Appropriate Formulation.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Oct; 18(7):2394-2409. PubMed ID: 28138820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
    Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.